Correction to: Mol Med (2018) 24:51
https://doi.org/10.1186/s10020-018-0052-3
Following publication of the original article (Gyetvai et al. 2018), the author Lamia Heikal would like to update her affiliation by adding a new one. The updated author affiliation is shown in this erratum.
Correct:
1Department of Clinical and Experimental Medicine, Brighton & Sussex Medical School, Brighton BN1 9PS, UK
2Department of Pharmaceutics, Faculty of Pharmacy, Alexandria University, Alexandria, 21521, Egypt
Reference
Gyetvai, et al. Mol Med. 2018;24:51. https://doi.org/10.1186/s10020-018-0052-3.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Gyetvai, G., Roe, C., Heikal, L. et al. Correction to: Leukemia inhibitory factor inhibits erythropoietin-induced myelin gene expression in oligodendrocytes. Mol Med 26, 62 (2020). https://doi.org/10.1186/s10020-020-00189-9
Published:
DOI: https://doi.org/10.1186/s10020-020-00189-9